Piper Sandler Sees 13% Downside in Rocket Lab Even After a Record Quarter
Piper Sandler maintained a Neutral rating on Rocket Lab (RKLB) but cut its price target to $58 from $83, citing uncertainty around Neutron rocket's launch date. Despite record revenue and backlog, earnings expectations for 2027 were reduced to 3 cents per share. The stock is down 56% from its May high.
How this was made
The 30-second read
Why it matters
The downgrade adds downside pressure and may trigger short‑term selling, while the strong backlog offers a longer‑term catalyst if launch timelines improve.
Market read
Analyst target cut after earnings creates immediate trading relevance for RKLB.
What to watch
Record $3.57 bn backlog and rising launch demand may support longer‑term upside despite short‑term uncertainty.
Background
Rocket Lab reported record revenue and backlog but missed earnings expectations; analyst Piper Sandler lowered its target citing launch‑date risk.
Ticker impact
Piper Sandler cut Rocket Lab's price target to $58, 13% below the current price, after a record‑revenue quarter but a loss and no Neutron launch date.
likely pressure as the market prices in the target cut and launch‑date uncertainty.
The downgrade is a fresh, material change with a specific price target; investors typically react negatively to such guidance.
Market effects
Space launch sector may see broader valuation compression as analysts scrutinize launch schedules.
US small‑cap and growth investors could adjust exposure to Rocket Lab and similar firms.
Limited to investors tracking the commercial space industry.
Counterpoint
If Neutron's launch materializes on schedule, the backlog and revenue growth could drive a rally.
Key entities
- companyRocket Lab
Space launch provider (ticker RKLB).
- analyst_firmPiper Sandler
Equity research firm issuing the downgrade.


